People · Operator
Named in public records as an officer, director or promoter · active 2013–2024 · Healthtech, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Conversio Health, LLC | — | Healthtech | Series B | $39.0M | $157.9M | 2013 |
| Isommune, LLC | — | Biotechnology | Pre-Seed | $275K | $15.2M | 2016 |
James Hoxter at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James Hoxter on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jonathan Phillips | 2 | 14 |
| Kirk Clove | 2 | 2 |
| Pat Cline | 2 | 2 |
| Rachel Kern | 1 | 7 |
| Rock Morphis | 1 | 5 |
| JON PHILLIPS | 1 | 5 |
| Christopher Dooley | 1 | 4 |
| Jesse Bland | 1 | 3 |
| Patrick Cline | 1 | 3 |
| Richard Frank | 1 | 2 |
| Amanda Bringe | 1 | 1 |
| Bartho Van Otterdyk | 1 | 1 |
| Devraj Mukherjee | 1 | 1 |
| Matt Etheridge | 1 | 1 |
| Kelly Frazier | 1 | 1 |
| Christian Barrett | 1 | 1 |
| Michael Holohan | 1 | 1 |
| Dennis Carson | 1 | 1 |
| Scott Waddell | 1 | 1 |
| Taylor Cline | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.